These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18220807)

  • 1. Non enzymatic glycated proteins in the blood and cardiovascular disease.
    Misciagna G; De Michele G; Trevisan M
    Curr Pharm Des; 2007; 13(36):3688-95. PubMed ID: 18220807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
    George C; Matsha TE; Korf M; Zemlin AE; Erasmus RT; Kengne AP
    BMC Nephrol; 2020 Jan; 21(1):32. PubMed ID: 32000712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
    Reaven PD; Herold DA; Barnett J; Edelman S
    Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differences in the formation of plasma glycated proteins between dogs and humans under diabetes-like glucose concentration conditions.
    Rivera-Velez SM; Hwang J; Navas J; Villarino NF
    Int J Biol Macromol; 2019 Feb; 123():1197-1203. PubMed ID: 30465839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced glycation of hemoglobin and plasma proteins is associated with increased lipid peroxide levels in non-diabetic hypertensive subjects.
    Sathiyapriya V; Selvaraj N; Nandeesha H; Bobby Z; Agrawal A; Pavithran P
    Arch Med Res; 2007 Nov; 38(8):822-6. PubMed ID: 17923261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quest for the perfect biomarker of long-term glycemia: new studies, new trials and tribulations.
    Foo JP; Mantzoros CS
    Metabolism; 2011 Dec; 60(12):1651-4. PubMed ID: 21820137
    [No Abstract]   [Full Text] [Related]  

  • 13. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
    Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
    Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring diabetic control in developing countries: a review of glycated haemoglobin and fructosamine assays.
    Rahlenbeck SI
    Trop Doct; 1998 Jan; 28(1):9-15. PubMed ID: 9481190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum fructosamine assay specific for determination of glycated serum protein?
    Schleicher ED; Mayer R; Wagner EM; Gerbitz KD
    Clin Chem; 1988 Feb; 34(2):320-3. PubMed ID: 3124979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructosamine, glycated hemoglobin, and dietary carbohydrates.
    Misciagna G; Logroscino G; De Michele G; Cisternino AM; Guerra V; Freudenheim JL
    Clin Chim Acta; 2004 Feb; 340(1-2):139-47. PubMed ID: 14734205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control.
    Wörner W; Pfleiderer S; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycated albumin in diabetic patients with chronic kidney disease.
    Zheng CM; Ma WY; Wu CC; Lu KC
    Clin Chim Acta; 2012 Oct; 413(19-20):1555-61. PubMed ID: 22579765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assays of HbA1c and Amadori products in human biology].
    Gillery P
    Ann Pharm Fr; 2014 Sep; 72(5):330-6. PubMed ID: 25220229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.